A 3- to 5-day Clinical Trial of Levamisole in Loiasis Infected Subjects

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

Republic of the Congo

Supervisor, Sibiti, Komono

General Supervisor, Sibiti, Mokassi

Phase

Safety & dosing / Large-scale testing

Sponsor

Programme National de Lutte contre l'Onchocercose, Republic of the Congo

Collaborators

Institut de Recherche pour le Developpement

Enrollment target

~99 participants

Started

June 2024

Primary completion

September 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 65 Years

Last updated September 2024